Whether and when an AIDS vaccine? (original) (raw)

Nature Medicine volume 1, pages 1126–1129 (1995) Cite this article

The level of scientific understanding required to develop a successful AIDS vaccine is still lacking, although the elements needed to pursue a practical and productive vaccine development program can be defined.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Scientific and public health rationale for HIV vaccine efficacy trials. AIDS 9, WHO1–WHO4 (1995).
  2. Hilleman, M.R., Practical insights from comparative immunology and pathogenesis of AIDS, hepatitis, and measles for developing an HIV vaccine. Vaccine (in the press).
  3. Donnelly, J.J. et al. Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus. Nature Med. 1, 583–587 (1995).
    Article CAS Google Scholar
  4. Rimmelzwaan, G.F. & Osterhaus, A.D.M.E. Cytotoxic T lymphocyte memory: Role in cross-protective immunity against influenza? Vaccine 13, 703–705 (1995).
    Article CAS Google Scholar
  5. Hilleman, M.R. Comparative biology and pathogenesis of AIDS and Hepatitis B viruses: Related but different. AIDS Res. hum. Retrovir. 10, 1409–1419 (1994).
    Article CAS Google Scholar
  6. Hilleman, M.R., cinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS. AIDS Res. hum. Retrovir. 10, 3–12 (1994).
    Article CAS Google Scholar
  7. Griffin, D., Ward, B. & Esolen, L.M. Pathogenesis of measles virus infection: An hypothesis of altered immune responses. J. infect. Dis. 170 (suppl.), S24–S31 (1994).
    Article Google Scholar
  8. Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. & Desrosiers, R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938–1941 (1992).
    Article CAS Google Scholar
  9. Baba, T.W. et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 427, 1820–1825 (1995).
    Article Google Scholar
  10. Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).
    Article CAS Google Scholar
  11. Pantaleo, G., Graziosi, C. & Fauci, A.S. The immunopathogenesis of human immunodeficiency virus infection. New Engl. J. Med. 328, 327–335 (1993).
    Article CAS Google Scholar
  12. Levy, J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183–289 (1993).
    CAS PubMed PubMed Central Google Scholar
  13. Kurth, R. et al. Pathogenic mechanisms in HIV and SIV infections. in Animal Models of HIV and Other Retroviral Infections (eds Racz, P., Letvin, N.L. & Gluckman, J.D.) 39–48 (Karger, Basel, 1993).
    Google Scholar
  14. Clerici, M. & Shearer, G.M. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immun. Today 114, 107–111 (1993).
    Article Google Scholar
  15. Mosmann, T.R. Cytokine patterns during the progression to AIDS. Science 265, 193–194 (1994).
    Article CAS Google Scholar
  16. Ennen, J. et al. CD8+ T lymphocytes of African Green Monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc. natn. Acad. Sci. U.S.A. 91, 7207–7214 (1994).
    Article CAS Google Scholar
  17. Hilleman, M.R., Impediments, imponderables and alternatives in the attempt to develop an effective vaccine against AIDS. Vaccine 10, 1053–1058 (1992).
    Article CAS Google Scholar
  18. Fields, B.N. AIDS: Time to turn to basic science. Nature 369, 95–96 (1994).
    Article CAS Google Scholar
  19. Paul, W.E. Reexamining AIDS research priorities. Science 267, 633–636 (1995).
    Article CAS Google Scholar
  20. Simon-Moffat, A. Exploring transgenic plants as a new vaccine source. Science 268, 658–660 (1995).
    Article Google Scholar

Download references

Author information

Authors and Affiliations

  1. Merck Institute for Therapeutic Research, Merck Research Laboratories, West Point, Pennsylvania, 19486, USA
    Maurice R. Hilleman

Authors

  1. Maurice R. Hilleman

Rights and permissions

About this article

Cite this article

Hilleman, M. Whether and when an AIDS vaccine?.Nat Med 1, 1126–1129 (1995). https://doi.org/10.1038/nm1195-1126

Download citation